MoneyWorks4Me

Lactose India - Quaterly Results

21 May 2026 Evaluate
The turnover is pegged at Rs. 457.66 millions for the March 2026 quarter. The mentioned figure indicates a rise of about 64.80% as against Rs. 277.71 millions during the year-ago period.The Total revenue for the quarter ended March 2026 of  Rs. 18.77  millions  grew by 191.91% from Rs. 6.43 millions.Operating profit for the quarter ended March 2026 rose to 52.40 millions as compared to 37.81 millions of corresponding quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 457.66 277.71 64.80 1632.90 1163.99 40.28 1632.90 1163.99 40.28
Other Income 2.15 3.71 -42.05 10.72 14.54 -26.27 10.72 14.54 -26.27
PBIDT 52.40 37.81 38.59 194.49 184.12 5.63 194.49 184.12 5.63
Interest 14.30 18.38 -22.20 50.86 61.03 -16.66 50.86 61.03 -16.66
PBDT 38.10 19.43 96.09 143.63 123.09 16.69 143.63 123.09 16.69
Depreciation 15.01 13.94 7.68 57.42 53.91 6.51 57.42 53.91 6.51
PBT 23.09 5.49 320.58 86.21 69.18 24.62 86.21 69.18 24.62
TAX 4.32 -0.94 -559.57 25.58 17.54 45.84 25.58 17.54 45.84
Deferred Tax 2.68 -2.86 -193.71 13.40 4.38 205.94 13.40 4.38 205.94
PAT 18.77 6.43 191.91 60.63 51.64 17.41 60.63 51.64 17.41
Equity 125.89 125.89 0.00 125.89 125.89 0.00 125.89 125.89 0.00
PBIDTM(%) 11.45 13.61 -15.90 11.91 15.82 -24.70 11.91 15.82 -24.70
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..